September 12, 2016
New Board member to Verona Pharma
Verona Pharma #VRP appoints Vikas Sinha to the Board as a Non-Executive Director
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
September 12, 2016
Karuna and PureTech comparing KarXI to xanomeline (Alzheimer’s and Schizophrenia)
The study, which will be conducted in up to 70 healthy individuals, aims to evaluate the tolerability of KarXT compared to xanomeline alone.
September 9, 2016
First Dechra’s FDA approval for US generic entrant antibiotic
Dechra, an international specialist veterinary pharmaceuticals company, has received approval from the U.S. Food and Drug Administration (FDA) for a generic antibiotic.
September 8, 2016
Redx CFO steps down, the company searches new one
Redx CFO steps down, the company searches new one
September 8, 2016
Premaitha Health welcomes new board member
David Evans, Non-executive Chairman, has stepped down from the Board with immediate effect.
September 6, 2016
Quay Pharma to formulate capsules to be be administered in Redx’s trial
Quay Pharma will be formulating the capsules that will be administered in Redx’s trial.
September 6, 2016
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
August 25, 2016
Positive Phase III EXPAND study for Novartis
Positive Phase III EXPAND study for Novartis
July 29, 2016
Sanofi reports net income €1,158m, down 11.1%
“Second quarter financial performance was in-line with expectations.” – Olivier Brandicourt, Sanofi CEO
July 25, 2016
Faron and Abzena in cancer medicine Clevegen manufacture deal
Faron and Abzena in cancer medicine Clevegen manufacture deal